𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Radiosynthesis of high effective specific-activity [123I]SCH 23982 for dopamine D-1 receptor-based SPECT imaging

✍ Scribed by Stephen M. Moerlein; David Parkinson; Michael J. Welch


Publisher
Elsevier Science
Year
1990
Weight
478 KB
Volume
41
Category
Article
ISSN
0883-2889

No coin nor oath required. For personal study only.

✦ Synopsis


The high yield, high-specific activity radiosynthesis of the dopaminergic D-1 receptor-binding ligand [123I]SCH 23982 is described. Using no-carrier-added iododeprotonation of the des-iodo precursor SKF 83692 and column-switching HPLC, [123I]SCH 23982 was isolated in 35-40% radiochemical yield with an effective specific activity of 2250-4000 Ci/mmol and an overall preparation time of 90 min. The procedure outlined here can be employed for the clinical production of [123I]SCH 23982 as a SPECT radiopharmaceutical, as well as [125I]SCH 23982 to be used for in vitro receptor-binding applications.


πŸ“œ SIMILAR VOLUMES


Large scale preparation strategy for lab
✍ H.-F. Beer; Sha Lin; I. Novak-Hofer; P. BlΓ€uenstein; P.A. Schubiger πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier Science βš– 475 KB

The labelling of the D1 antagonist SCH 23982 with 123I was studied in detail by following the nucleophilic and electrophilic approaches and the reaction conditions were optimized. The product was purified by reversed phase HPLC with a phosphoric acid/EtOH mixture which simply has to be neutralized a

4-123I - spiperone of high purity and hi
✍ J. Mertens; D. Terriere; A. Bossuyt; C. Bossuyt-Piron πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 104 KB

Recently there has been an increased urge towards y-labelled tracers for in vivo dopamine receptors studies in human brain with SPECT. As 99m Tc chelate compunds for that purpose remain wishfull thinking until now, only 123 I labelled molecules can actually fulfil the technical requirements of imagi